- Home
- GTLS vs ELAN Comparison
GTLS vs ELAN Comparison
Compare GTLS & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GTLS | ELAN |
|---|---|---|
| Founded | 1859 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 10.3B |
| IPO Year | 1992 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GTLS | ELAN |
|---|---|---|
| Price | $207.43 | $24.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $205.40 | $24.44 |
| AVG Volume (30 Days) | 770.2K | ★ 4.8M |
| Earning Date | 02-27-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.86 | 0.07 |
| Revenue | $4,291,200,000.00 | ★ $4,591,000,000.00 |
| Revenue This Year | $8.33 | $7.25 |
| Revenue Next Year | $11.45 | $5.80 |
| P/E Ratio | ★ $240.40 | $355.89 |
| Revenue Growth | ★ 5.47 | 3.08 |
| 52 Week Low | $104.60 | $8.02 |
| 52 Week High | $216.44 | $25.63 |
Technical Indicators
Market Signals| Indicator | GTLS | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 64.71 | 57.33 |
| Support Level | $207.05 | $24.16 |
| Resistance Level | $207.61 | $25.63 |
| Average True Range (ATR) | 0.51 | 0.67 |
| MACD | -0.08 | -0.04 |
| Stochastic Oscillator | 44.18 | 46.51 |
Price Performance
Historical ComparisonAbout GTLS Chart Industries Inc.
Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company. It plans to merge with Flowserve by the end of 2025.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.